Xenex LightStrike UV Robots Deactivate SARS-CoV-2 on Surfaces in 2 Minutes in New Peer-Reviewed Study

8-Oct-2020 4:15 PM EDT, by Xenex Disinfection Services

Newswise — The LightStrike pulsed xenon disinfection robot is the first ultraviolet (UV) room disinfection technology proven to deactivate SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2). The LightStrike robot achieved a greater than 99.99% level of disinfection against SARS-CoV-2, which is the virus that causes COVID-19, in two minutes. Testing was performed in a biosafety level 4 lab at Texas Biomedical Research Institute, one of the world’s leading independent research institutes working exclusively on infectious diseases.

The new peer-reviewed and published study, titled “Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control” is published in Infection Control and Hospital Epidemiology. The authors include highly regarded physicians and infectious disease experts from the Central Texas Veterans Healthcare System, HonorHealth, Mayo Clinic, Texas Biomedical Research Institute, The University of Texas MD Anderson Cancer Center, University of Michigan, University of California-San Francisco, West Virginia University Medicine, and Xenex.

“Deactivating SARS-CoV-2 on surfaces is a critical and necessary step to protect people as businesses and schools begin to reopen and people return to work. Individuals with COVID-19 and asymptomatic carriers of SARS-CoV-2 contaminate their environment, and SARS-CoV-2 has been shown to be viable on surfaces for up to three days,” said Dr. Mark Stibich, Chief Scientific Officer of Xenex. “We convened a panel of some of the world’s leading infectious disease experts to validate the efficacy of pulsed xenon UV disinfection against SARS-CoV-2, and to confirm the LightStrike robot’s role as an important tool in the battle against the pandemic.”

LightStrike Germ-Zapping Robots™ use a xenon lamp to generate bursts of high intensity, broad spectrum (200-315nm) UV light. Different pathogens are susceptible to UV light at different wavelengths. With broad spectrum UV light, Xenex LightStrike robots quickly deactivate viruses, bacteria and spores at the specific wavelengths of light where the pathogens are most vulnerable without damaging materials or surfaces. More than 40 peer-reviewed studies have been published validating the efficacy of the LightStrike technology, which is now being used not only in healthcare facilities but in hotels, schools, professional sports facilities, office buildings and corporate headquarters, airports, police stations and jails, government buildings, and food processing facilities.

Prior to peer-review, Xenex’s SARS-CoV-2 efficacy results were shared in a study published on medRxiv on May 11, 2020.

About Xenex

Xenex is a world leader in UV technology-based disinfection strategies and solutions, working closely with hospitals’ infection control and EVS personnel to reduce the presence of dangerous pathogens in their facilities to provide a safer environment for patients and staff. Xenex's mission is to save lives and reduce suffering by destroying the deadly microorganisms that can cause infections. Xenex is backed by well-known investors that include EW Healthcare Partners, Piper Jaffray, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit xenex.com.

 

###

 

 

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 4147
access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVID’s Collateral Damage: Germicidal Lamps May Damage Corneas
Released: 24-Nov-2020 5:15 PM EST
COVID’s Collateral Damage: Germicidal Lamps May Damage Corneas
University of Miami Health System, Miller School of Medicine

In a paper published in the journalOcular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus, developed painful inflammation of the cornea, a condition called photokeratitis.

Released: 24-Nov-2020 4:35 PM EST
Cleveland Clinic Research Shows Bariatric Surgery May Reduce Severity of COVID-19 in Patients with Obesity
Cleveland Clinic

CLEVELAND: A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission. The results were published in the journal of Surgery for Obesity and Related Diseases.

Newswise: 249693_web.jpg
Released: 24-Nov-2020 3:40 PM EST
New therapy for flu may help in fight against COVID-19
Purdue University

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

Released: 24-Nov-2020 3:30 PM EST
‘Crisis decision making at the speed of COVID-19’ – Bay Area public health officials share their experience with shelter-in-place order
Wolters Kluwer Health: Lippincott

In mid-March, public health officials across the San Francisco area issued the first U.S. regional shelter-in-place order in response to the emerging COVID-19 pandemic. A “field report” on the crisis decision-making approach followed in that effective early response is featured in a special COVID-19 supplement to the Journal of Public Health Management and Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Research Helps Identify High-Risk Populations to aid
Health Officials Combating the Pandemic
Released: 24-Nov-2020 3:25 PM EST
Research Helps Identify High-Risk Populations to aid Health Officials Combating the Pandemic
UCLA Fielding School of Public Health

A team of UCLA Fielding School of Public Health researchers has developed a method to better guide public policy related to the control and prevention of COVID-19, based on identifying those most at risk in the pandemic

Released: 24-Nov-2020 3:15 PM EST
Workplace Expert: COVID-Safe Company Holiday Party Ideas and Why Celebrating is Significant
University of Maryland, Robert H. Smith School of Business

Maryland Smith workplace expert Vijaya Venkataramani says Zoom fatigue notwithstanding, a COVID-safe staff or company holiday celebration is ideal for leaders and managers to give thanks to team members for their resilience in 2020.

Newswise: Schooling Disrupted by the Pandemic in the United States Likely to Have Life-Long Impact, Study Says
Released: 24-Nov-2020 3:10 PM EST
Schooling Disrupted by the Pandemic in the United States Likely to Have Life-Long Impact, Study Says
UCLA Fielding School of Public Health

A team that includes UCLA Fielding School of Public Health researchers has found American children whose educations have been disrupted by the pandemic, even as little as 2-4 months, may face shortened life spans.


Showing results

1120 of 4147

close
1.08109